ストックスクリーナーアプリを入手
52.17
0.56%
0.29
アフターアワーズ：
52.08
-0.09
-0.17%
前日終値:
$51.88
開ける：
$51.71
24時間の取引高:
190.98K
Relative Volume:
0.68
時価総額：
$3.29B
収益：
-
当期純損益:
$-80.77M
株価収益率:
-44.62
EPS:
-1.1692
ネットキャッシュフロー:
$-80.80M
1週間 パフォーマンス:
+1.62%
1か月 パフォーマンス:
+4.72%
6か月 パフォーマンス:
+32.11%
1年 パフォーマンス:
-9.32%
1日の値動き範囲:
$50.21
$54.10
1週間の範囲:
$50.21
$58.26
52週間の値動き範囲:
$37.55
$64.98
Moonlake Immunotherapeutics Stock (MLTX) Company Profile
MLTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MLTX
Moonlake Immunotherapeutics
|
52.17 | 3.29B | 0 | -80.77M | -80.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Moonlake Immunotherapeutics Stock (MLTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-05 | 再開されました | Wedbush | Outperform |
| 2024-08-26 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | 開始されました | Oppenheimer | Outperform |
| 2024-04-02 | 開始されました | Goldman | Neutral |
| 2024-02-15 | 開始されました | Wolfe Research | Outperform |
| 2023-12-08 | 開始されました | Citigroup | Buy |
| 2023-11-02 | 開始されました | Stifel | Buy |
| 2023-09-14 | ダウングレード | Bryan Garnier | Buy → Neutral |
| 2023-08-31 | 開始されました | Needham | Buy |
| 2023-06-15 | 開始されました | Barclays | Equal Weight |
| 2023-05-01 | 開始されました | Guggenheim | Buy |
| 2023-03-22 | 開始されました | Wedbush | Outperform |
| 2023-03-09 | 開始されました | BTIG Research | Buy |
| 2023-02-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-02-02 | 開始されました | Bryan Garnier | Buy |
| 2022-11-11 | 開始されました | Jefferies | Buy |
| 2022-08-25 | 開始されました | SVB Leerink | Outperform |
| 2022-07-21 | 開始されました | H.C. Wainwright | Buy |
| 2022-07-07 | 開始されました | Cowen | Outperform |
すべてを表示
Moonlake Immunotherapeutics (MLTX) 最新ニュース
MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Down 3.2%What's Next? - MarketBeat
MoonLake Immunotherapeutics announces board change, incentive plan - Investing.com
MoonLake Immunotherapeutics Announces Board Changes and Incentives - TipRanks
MoonLake Immunotherapeutics announces board change, incentive plan By Investing.com - Investing.com UK
MoonLake Immunotherapeutics (NASDAQ:MLTX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Up 7.9%Here's What Happened - MarketBeat
We're Not Very Worried About MoonLake Immunotherapeutics' (NASDAQ:MLTX) Cash Burn Rate - Simply Wall St
Wellington Management Group LLP Cuts Holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Position in MoonLake Immunotherapeutics (NASDAQ:MLTX) - MarketBeat
Trading (MLTX) With Integrated Risk Controls - Stock Traders Daily
MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Price Down 5.6%What's Next? - MarketBeat
MoonLake Immunotherapeutics' SWOT analysis: stock outlook amid HS market potential - Investing.com
Clear Street sets $108 target on Moonlake Immunotherapeutics stock By Investing.com - Investing.com UK
Clear Street sets $108 target on Moonlake Immunotherapeutics stock - Investing.com
MoonLake Immunotherapeutics Reports Q3 2024 Financial Results - MSN
MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Acquired by The Manufacturers Life Insurance Company - Defense World
When (MLTX) Moves Investors should Listen - Stock Traders Daily
Erste Asset Management GmbH Invests $741,000 in MoonLake Immunotherapeutics (NASDAQ:MLTX) - MarketBeat
Fmr LLC Purchases 1,306,215 Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX) - MarketBeat
Westfield Capital Management Co. LP Boosts Stock Holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX) - MarketBeat
(MLTX) Technical Pivots with Risk Controls - Stock Traders Daily
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives $79.00 Consensus PT from Brokerages - MarketBeat
MoonLake Immunotherapeutics: A Somewhat Complicated Story (NASDAQ:MLTX) - Seeking Alpha
Victory Capital Management Inc. Has $10.98 Million Stake in MoonLake Immunotherapeutics (NASDAQ:MLTX) - MarketBeat
MoonLake Immunotherapeutics Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
MoonLake Immunotherapeutics management to meet with Oppenheimer - TipRanks
MoonLake Immunotherapeutics' (MLTX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
MoonLake Immunotherapeutics' SWOT analysis: biopharma stock faces HS market potential, execution risks - Investing.com Canada
(MLTX) Pivots Trading Plans and Risk Controls - Stock Traders Daily
MoonLake Immunotherapeutics announces first patients screened in IZAR program - TipRanks
MoonLake Launches Major Phase 3 Trials for Psoriatic Arthritis Drug After Strong Phase 2 Results | MLTX Stock News - StockTitan
FMR LLC's Strategic Acquisition of MoonLake Immunotherapeutics S - GuruFocus.com
MoonLake Immunotherapeutics (MLTX) Quarterly 10-Q Report - Quartzy
MoonLake Immunotherapeutics (NASDAQ:MLTX) Releases Quarterly Earnings Results, Misses Estimates By $0.12 EPS - MarketBeat
HC Wainwright Reiterates Buy Rating for MoonLake Immunotherapeutics (NASDAQ:MLTX) - MarketBeat
Q3 Earnings Forecast for MLTX Issued By Wedbush - Defense World
What is Wedbush's Forecast for MLTX Q3 Earnings? - MarketBeat
MoonLake Immunotherapeutics reports Q3 EPS (56c), consensus (43c) - TipRanks
MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update - GlobeNewswire
MoonLake Reports $493.9M Cash Position, Advances Multiple Phase 3 Trials | MLTX Stock News - StockTitan
MoonLake Immunotherapeutics (NASDAQ:MLTX) Raised to "Strong-Buy" at Wedbush - MarketBeat
Wedbush Reiterates "Outperform" Rating for MoonLake Immunotherapeutics (NASDAQ:MLTX) - MarketBeat
AlphaCentric Advisors LLC Invests $706,000 in MoonLake Immunotherapeutics (NASDAQ:MLTX) - MarketBeat
MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Bought by Harbor Capital Advisors Inc. - MarketBeat
Long Term Trading Analysis for (MLTX) - Stock Traders Daily
75,469 Shares in MoonLake Immunotherapeutics (NASDAQ:MLTX) Acquired by Rice Hall James & Associates LLC - MarketBeat
MLTX Makes Notable Cross Below Critical Moving Average - Nasdaq
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives $80.45 Average PT from Brokerages - MarketBeat
MoonLake Immunotherapeutics (NASDAQ:MLTX) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
MoonLake Immunotherapeutics downgraded on concerns about lack of near-term catalysts - MSN
Moonlake Immunotherapeutics (MLTX) 財務データ
収益
当期純利益
現金流量
EPS
Moonlake Immunotherapeutics (MLTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Sturge Simon | Director |
Oct 04 '24 |
Sale |
53.72 |
171,000 |
9,186,120 |
171,980 |
| Santos da Silva Jorge | Chief Executive Officer |
Feb 27 '24 |
Sale |
55.00 |
62,810 |
3,454,550 |
3,043,619 |
| Santos da Silva Jorge | Chief Executive Officer |
Feb 28 '24 |
Sale |
55.00 |
56,065 |
3,083,575 |
2,987,554 |
| Santos da Silva Jorge | Chief Executive Officer |
Feb 29 '24 |
Sale |
55.89 |
4,740 |
264,919 |
2,982,814 |
| Reich Kristian | Chief Scientific Officer |
Feb 28 '24 |
Sale |
55.00 |
31,910 |
1,755,050 |
2,925,573 |
| Reich Kristian | Chief Scientific Officer |
Feb 27 '24 |
Sale |
55.00 |
29,491 |
1,622,005 |
2,957,483 |
| Reich Kristian | Chief Scientific Officer |
Feb 27 '24 |
Sale |
55.00 |
29,431 |
1,618,705 |
70,071 |
| Reich Kristian | Chief Scientific Officer |
Feb 28 '24 |
Sale |
55.00 |
28,090 |
1,544,950 |
41,981 |
| Santos da Silva Jorge | Chief Executive Officer |
Feb 21 '24 |
Sale |
55.27 |
1,125 |
62,179 |
3,106,429 |
| Reich Kristian | Chief Scientific Officer |
Feb 20 '24 |
Sale |
57.45 |
10,000 |
574,500 |
2,987,483 |
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):